Praram 9 Hospital Valuation
Is PR9-F undervalued compared to its fair value, analyst forecasts and its price relative to the market?
Valuation Score
2/6Valuation Score 2/6
Below Fair Value
Significantly Below Fair Value
Price-To-Earnings vs Peers
Price-To-Earnings vs Industry
Price-To-Earnings vs Fair Ratio
Analyst Forecast
Share Price vs Fair Value
What is the Fair Price of PR9-F when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.
Below Fair Value: PR9-F (THB18.9) is trading below our estimate of fair value (THB19.51)
Significantly Below Fair Value: PR9-F is trading below fair value, but not by a significant amount.
Key Valuation Metric
Which metric is best to use when looking at relative valuation for PR9-F?
Other financial metrics that can be useful for relative valuation.
What is PR9-F's n/a Ratio? | |
---|---|
n/a | 0x |
n/a | n/a |
Market Cap | ฿14.00b |
Key Statistics | |
---|---|
Enterprise Value/Revenue | 3x |
Enterprise Value/EBITDA | 13.5x |
PEG Ratio | 2.3x |
Price to Earnings Ratio vs Peers
How does PR9-F's PE Ratio compare to its peers?
Company | Forward PE | Estimated Growth | Market Cap |
---|---|---|---|
Peer Average | 34.9x | ||
WPH Wattanapat Hospital Trang | 43.7x | n/a | ฿8.1b |
MASTER Master Style | 41.5x | 21.5% | ฿18.7b |
SKR Sikarin | 22.9x | n/a | ฿21.0b |
CMR Chiang Mai Ram Medical Business | 31.6x | n/a | ฿7.7b |
PR9-F Praram 9 Hospital | 26.9x | 11.7% | ฿14.0b |
Price-To-Earnings vs Peers: PR9-F is good value based on its Price-To-Earnings Ratio (26.9x) compared to the peer average (38.9x).
Price to Earnings Ratio vs Industry
How does PR9-F's PE Ratio compare vs other companies in the TH Healthcare Industry?
Price-To-Earnings vs Industry: PR9-F is expensive based on its Price-To-Earnings Ratio (26.9x) compared to the TH Healthcare industry average (26.1x).
Price to Earnings Ratio vs Fair Ratio
What is PR9-F's PE Ratio compared to its Fair PE Ratio? This is the expected PE Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.
Fair Ratio | |
---|---|
Current PE Ratio | 26.9x |
Fair PE Ratio | n/a |
Price-To-Earnings vs Fair Ratio: Insufficient data to calculate PR9-F's Price-To-Earnings Fair Ratio for valuation analysis.
Analyst Price Targets
What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?
Analyst Forecast: Insufficient data to show price forecast.